Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen Chip vs Chlorhexidine Chip in Chronic Periodontitis
NCT01040286Phase 2Completed
- Sponsor
- Dexcel Pharma
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of flurbiprofen in chronic periodontitis (2 arms), sponsored by Dexcel Pharma. Primary endpoint: Mean Probing Pocket Depth reduction at 8 weeks. Started Aug 2009; status: completed.
02
Drugs
flurbiprofen
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT01040286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040286.